| Literature DB >> 2985516 |
Abstract
In an open trial, 35 patients suffering from a variety of dermatologic conditions were treated with thalidomide. The drug was shown to be a valuable addition to the therapeutic armamentarium; however, the occurrence of a peripheral neuropathy will limit its use just as its teratogenic side effects have done for many years.Entities:
Mesh：
Substances：
Year: 1985 PMID： 2985516 DOI： 10.1111/j.1365-4362.1985.tb05400.x
Source DB: PubMed Journal: Int J Dermatol ISSN： 0011-9059 Impact factor: 2.736